Enliven Therapeutics stock surges 28% on Merck-Terns deal
Go back to Enliven Therapeutics stock surges 28% on Merck-Terns deal| (NASDAQ: ELVN) | Delayed: 54.32 -1.91 (3.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.23 | 52 Week High | $ | |||
| Open | $57.00 | 52 Week Low | $ | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $54.12 | EPS | $ | |||
| Volume | 995,811 | |||||
| (NASDAQ: MAZE) | Delayed: 24.60 -0.22 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.82 | 52 Week High | $ | |||
| Open | $25.14 | 52 Week Low | $ | |||
| Day High | $25.99 | P/E | N/A | |||
| Day Low | $24.36 | EPS | $ | |||
| Volume | 1,052,241 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 143.93 -0.78 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.71 | 52 Week High | $65.46 | |||
| Open | $145.52 | 52 Week Low | $47.97 | |||
| Day High | $145.90 | P/E | 97.91 | |||
| Day Low | $143.68 | EPS | $1.47 | |||
| Volume | 8,731,993 | |||||
